Current Prices from Conduit Pharmaceuticals Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	CDT	USD	31.07.2025 12:51	1,79 USD	0,04 USD +2,29 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,56 %	-17,51 %	-35,38 %	-78,67 %	-95,32 %	-99,45 %	-99,99 %

Company Profile for Conduit Pharmaceuticals Inc. - Common Stock Share

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Company Data

Name Conduit Pharmaceuticals Inc. - Common Stock

Company Conduit Pharmaceuticals Inc.

Symbol CDT

Website https://www.conduitpharma.com

Primary Exchange

NASDAQ

ISIN US20678X1063

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Andrew Regan

Country United States of America

Currency USD

Employees 0,0 T

Address 4995 Murphy Canyon Road, 92134 San Diego

IPO Date 2022-03-28

Stock Splits

Date	Split
20.05.2025	1:15
27.01.2025	1:100

ID Changes

Date	From	To
25.09.2023	MURF	CDT

Ticker Symbols

Name	Symbol
Frankfurt	ZK7.F
NASDAQ	CDT

More Shares

Investors who hold Conduit Pharmaceuticals Inc. - Common Stock also have the following shares in their portfolio:

EXPEDIA GROUP 17/28 Bond

STAND.CHAR. 18/23 FLR MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog